Skip to main content
. 2020 Sep 1;15(9):e0238291. doi: 10.1371/journal.pone.0238291

Table 3. Total cost incurred with implementation of various screening strategies.

Screening strategy Screening cost in million Treatment expenditure in million Total cost in million*
INR US$ INR US$ INR US$
No organized screening 24 (16–34) 0.38 (0.20–0.50) 138 (72–248) 2.08 (1.10–3.7) 163 (96–275) 2.45 (1.45–4.16)
Visual inspection with acetic acid 3 Years 726 (521–972) 10.97 (7.90–14.70) 61 (32–109) 0.93 (0.50–1.65) 789 (576–1046) 11.92 (8.70–15.80)
5 Years 380 (276–503) 5.74 (4.16–7.60) 80 (41–136) 1.20 (0.6–2.06) 462 (348–599) 6.98 (5.26–9.04)
10 Years 221 (162–291) 3.34 (2.4–4.4) 98 (48–176) 1.48 (0.75–2.5) 319 (241–417) 4.82 (3.64–6.3)
PAP smear 3 Years 787 (556–1103) 11.88 (8.40–16.67) 67 (34–127) 1.02 (0.51–1.92) 855 (621–1172) 12.91 (9.37–17.71)
5 Years 418 (289–595) 6.31 (3.36–9.0) 85 (43–155) 1.28 (0.65–2.34) 508 (363–692) 7.67 (5.48–10.45)
10 Years 241 (166–340) 3.64 (2.50–5.13) 102 (51–186) 1.54 (0.77–2.81) 345 (246–471) 5.21 (3.72–7.12)
HPV DNA test 3 Years 1042 (763–1436) 15.74 (11.53–21.70) 53 (28–97) 0.80 (0.42–1.46) 1101 (813–1849) 16.64 (12.30–22.50)
5 Years 574 (410–803) 8.67 (6.20–12.13) 72 (37–130) 1.09 (0.56–1.96) 647 (479–880) 9.77 (7.24–13.29)
10 Years 326 (238–450) 4.93 (3.59–6.80) 93 (49–170) 1.40 (0.74–2.56) 423 (318–570) 6.39 (4.80–8.60)

*Total cost in a cohort of 100,000population; Pap: Papanicolaou test; Values in parenthesis represent 2.5th and 97.5th percentile; US$: Unites States Dollar; INR: Indian rupees